Coronavirus Update:What patients and families need to know
Blood and Marrow
Discover the conditions we treat and treatments we provide at Children's National Hospital. Providers at Children's National work with you and your family to decide on the best care plan for your child. Learn more about the Center for Cancer and Blood Disorders.
Allogeneic transplantation is a procedure in which a person receives hematopoietic (blood-forming) or blood stem cells, from a genetically similar, but not identical, donor.
Alpha thalassemia is an inherited blood disorder. This means it is passed down through the parent’s genes. It may cause anemia in their children. Learn more about this condition.
Fanconi anemia is a blood disorder in which the bone marrow doesn't make enough blood cells or makes abnormal types of blood cells. Learn more about this condition.
Hemolytic anemia is a disorder in which the red blood cells are destroyed faster than the bone marrow can produce them.
Anemia is a common health problem in children. The most common cause of anemia is not getting enough iron. Learn more about this condition.
Megaloblastic anemia is a type of anemia characterized by very large red blood cells. In addition to the cells being large, the inner contents of each cell are not completely developed. Learn more about this condition.
Aplastic anemia occurs when the bone marrow produces too few of all types of blood cells: red cells, white cells, and platelets. Learn more about this condition.
Many patients come to the transplant program at Children's National Hospital because of its excellent reputation in the field of pediatric Blood and Marrow Transplantation (BMT). Learn more about autologous transplantation treatment.
Beta thalassemia is caused by genetic defects that control the production of hemoglobin, and treatment includes regular blood transfusions. Learn more about this condition.
Peripheral blood stem cell (PBSC) collection is a procedure where volunteer donors (relatives or siblings) or patients donate their stem cells through apheresis for allogeneic and autologous blood and marrow transplantation. Learn more about this treatment.